Cypherpunk Technologies

Cypherpunk Technologies Enterprise Value

The Enterprise Value (EV) of Cypherpunk Technologies (CYPH) as of Oct 16, 2026 is -7.03 M USD. In the previous year, Enterprise Value (EV) was -30.43 M USD — a change of -76.89% (higher).

Enterprise Value

-7.03 MUSD

YoY

-76.89%

Last updated:

Enterprise Value (EV) of Cypherpunk Technologies is 2024 -7.03 M USD. Enterprise Value (EV) of Cypherpunk Technologies was 2023 -30.43 M USD. It decreases by -76.89% higher compared to the previous year.

The Cypherpunk Technologies Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2017
14.48 M USD
Jan 1, 2018
23.93 M USD
Jan 1, 2019
36.33 M USD
Jan 1, 2020
-11.85 M USD
Jan 1, 2021
-74.70 M USD
Jan 1, 2022
-25.28 M USD
Jan 1, 2023
-30.43 M USD
Jan 1, 2024
-7.03 M USD
The Cypherpunk Technologies Enterprise Value history
YEAREnterprise ValueYoY
-7.03 MUSD-76.89%
-30.43 MUSD+20.34%
-25.28 MUSD-66.15%
-74.70 MUSD+530.17%
-11.85 MUSD-132.63%
36.33 MUSD+51.78%
23.93 MUSD+65.28%
14.48 MUSD-79.22%
69.70 MUSD+62.27%
42.95 MUSD-0.39%
43.12 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cypherpunk Technologies Stock analysis

What does Cypherpunk Technologies do? Cypherpunk Technologies Inc, trading under the ticker CYPH, is a biotechnology company based in Cambridge, United States. The company has a small workforce of six employees. It went public with an IPO on January 24, 2017. The company's website is https://www.leaptx.com/. The source description provided by the user contains unverified information, including the company's headquarters in Cambridge, Massachusetts, and details about its clinical stage programs, which are not confirmed by the facts provided. The source also mentions the company having 24 employees, which contradicts the provided employee count of six. Additionally, the source describes the company as developing monoclonal antibodies targeting cancer pathways, but these details are not part of the verified facts. The company's actual focus and product pipeline remain unconfirmed based on the information given. The source also incorrectly identifies the company as Leap Therapeutics, Inc., which is not the official name provided. The website provided, https://www.leaptx.com/, appears to be related to Leap Therapeutics, not Cypherpunk Technologies Inc. Therefore, the description is limited to the verified facts: the company's name, ticker, ISIN, country, city, sector, industry, employee count, IPO date, and website. No additional details about products, programs, or specific therapeutic targets can be included due to lack of verified information. Cypherpunk Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cypherpunk Technologies stock

Enterprise Value (EV) of Cypherpunk Technologies is -7.03 M USD in 2024.

Enterprise Value (EV) of Cypherpunk Technologies changed from -30.43 M USD to -7.03 M USD, representing a -76.89% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Cypherpunk Technologies since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s USD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' USD varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Cypherpunk Technologies with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Cypherpunk Technologies

All Key Metrics — Cypherpunk Technologies